Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

8 structures for O95150

Entry ID Method Resolution Chain Position Source
2O0O X-ray 300 A A/B/C 72-251 PDB
2QE3 X-ray 250 A A 72-251 PDB
2RE9 X-ray 210 A A/B/C 72-251 PDB
2RJK X-ray 230 A A 72-251 PDB
2RJL X-ray 205 A A 72-251 PDB
3K51 X-ray 245 A A 72-251 PDB
3MI8 X-ray 295 A A 72-251 PDB
AF-O95150-F1 Predicted AlphaFoldDB

195 variants for O95150

Variant ID(s) Position Change Description Diseaes Association Provenance
rs1564348710
CA374687431
2 A>P No ClinGen
Ensembl
CA5207096
rs371110841
3 E>K No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA5207095
rs765222060
6 G>E No ClinGen
ExAC
gnomAD
rs1357593846
CA374687398
7 L>P No ClinGen
gnomAD
rs757409599
CA5207094
8 S>N No ClinGen
ExAC
gnomAD
rs140689831
CA374687382
9 F>L No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA374687386
rs1399648493
9 F>S No ClinGen
gnomAD
CA5207092
rs764654587
10 G>R No ClinGen
ExAC
gnomAD
CA5207090
rs775935352
11 E>D No ClinGen
ExAC
gnomAD
CA5207091
rs761282953
11 E>K No ClinGen
ExAC
TOPMed
gnomAD
CA374687370
rs1587903804
12 T>P No ClinGen
Ensembl
rs1218308722
CA374687364
13 A>T No ClinGen
TOPMed
CA5207088
rs369441005
CA5207087
14 S>R No ClinGen
ExAC
TOPMed
gnomAD
rs767994309
CA5207089
14 S>R No ClinGen
ExAC
gnomAD
rs562601626
CA5207086
16 E>K No ClinGen
1000Genomes
ExAC
gnomAD
CA374687333
rs1587903793
17 M>I No ClinGen
Ensembl
rs1047533515
CA198901216
20 E>D No ClinGen
Ensembl
CA198901217
rs56129146
20 E>K No ClinGen
Ensembl
CA5207085
rs146813484
21 H>Q No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
TCGA novel 21 H>R Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA374687306
rs768523743
22 G>C No ClinGen
ExAC
TOPMed
gnomAD
CA5207082
rs576932402
22 G>D No ClinGen
1000Genomes
ExAC
gnomAD
CA5207083
rs768523743
22 G>S No ClinGen
ExAC
TOPMed
gnomAD
rs1400935280
CA374687287
25 R>G No ClinGen
TOPMed
rs150191342
RCV000904737
CA5207080
25 R>K No ClinGen
ClinVar
1000Genomes
ESP
ExAC
TOPMed
dbSNP
gnomAD
rs150191342
CA374687285
25 R>T No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
CA198901215
rs368232426
26 P>L No ClinGen
ESP
TOPMed
CA374687279
rs1363558322
26 P>S No ClinGen
TOPMed
rs746059555
COSM1582778
CA5207079
27 K>E stomach [Cosmic] No ClinGen
cosmic curated
ExAC
TOPMed
gnomAD
CA198901214
rs750605115
28 A>T No ClinGen
Ensembl
CA374687261
rs1279043315
29 R>K No ClinGen
TOPMed
CA5207078
rs779239225
30 S>N No ClinGen
ExAC
gnomAD
rs757455616
CA5207077
31 S>R No ClinGen
ExAC
gnomAD
rs140925489
CA5207076
32 S>G No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs753318529
CA5207073
33 A>S No ClinGen
ExAC
TOPMed
gnomAD
CA5207074
rs753318529
33 A>T No ClinGen
ExAC
TOPMed
gnomAD
rs55683440
CA5207072
34 R>C No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA5207071
rs201981566
34 R>H No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
rs201981566
CA198901213
34 R>P No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
rs1233763127
CA374687220
36 A>T No ClinGen
gnomAD
rs772707672
CA5207070
36 A>V No ClinGen
ExAC
gnomAD
rs377131025
CA5207069
37 L>F No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA374687214
rs377131025
37 L>V No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs1160125356
CA374687182
42 V>L No ClinGen
TOPMed
rs142809540
CA198901212
43 L>W No ClinGen
ESP
CA374687163
rs1587903714
45 P>S No ClinGen
Ensembl
CA374687153
rs1365054184
46 F>L No ClinGen
TOPMed
gnomAD
rs1320756540
CA374687147
47 L>P No ClinGen
gnomAD
rs866462140
CA198901210
48 A>T No ClinGen
Ensembl
rs761388330
CA5207067
48 A>V No ClinGen
ExAC
TOPMed
gnomAD
rs776054186
CA5207066
49 G>E No ClinGen
ExAC
gnomAD
CA374687133
rs1392705533
50 L>H No ClinGen
TOPMed
CA5207065
rs768222774
51 T>I No ClinGen
ExAC
gnomAD
CA198901208
rs961818106
56 V>L No ClinGen
TOPMed
CA5207062
rs771826971
57 S>R No ClinGen
ExAC
gnomAD
rs527825986
CA198901207
58 Q>R No ClinGen
Ensembl
CA374687078
rs745637627
59 L>P No ClinGen
ExAC
TOPMed
gnomAD
CA5207061
rs745637627
59 L>R No ClinGen
ExAC
TOPMed
gnomAD
CA198901206
rs1028941301
60 R>Q No ClinGen
TOPMed
gnomAD
CA5207060
rs554137268
60 R>W No ClinGen
1000Genomes
ExAC
gnomAD
rs1271897082
CA374687071
61 A>S No ClinGen
gnomAD
CA374687066
rs1294409455
62 Q>E No ClinGen
TOPMed
rs1294409455
CA374687067
62 Q>K No ClinGen
TOPMed
CA374687063
rs749472080
62 Q>P No ClinGen
ExAC
TOPMed
gnomAD
CA5207058
rs749472080
62 Q>R No ClinGen
ExAC
TOPMed
gnomAD
CA5207057
rs777991000
63 G>E No ClinGen
ExAC
gnomAD
rs756319889
CA5207056
65 A>V No ClinGen
ExAC
CA374687037
rs1374591489
66 C>F No ClinGen
TOPMed
gnomAD
CA374687039
rs1374591489
66 C>Y No ClinGen
TOPMed
gnomAD
rs781774264
CA5207054
67 V>A No ClinGen
ExAC
gnomAD
rs537486487
CA5207055
67 V>L No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
CA374687019
rs1587903647
69 F>Y No ClinGen
Ensembl
rs1290124561
CA374687012
70 Q>* No ClinGen
gnomAD
TCGA novel 72 L>I Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA374686981
rs1240942553
72 L>P No ClinGen
gnomAD
CA5207033
rs780453763
73 K>E No ClinGen
ExAC
gnomAD
CA5207032
rs201039485
76 E>K No ClinGen
1000Genomes
ExAC
gnomAD
rs753461731
CA5207031
79 P>A No ClinGen
ExAC
TOPMed
gnomAD
CA374686921
rs1206745818
81 H>R No ClinGen
gnomAD
CA374686910
rs1446425593
82 Q>H No ClinGen
gnomAD
rs1290489216
CA374686909
83 Q>* Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
rs1461120016
CA374686876
85 Y>* No ClinGen
gnomAD
CA374686864
rs1254888631
87 P>H No ClinGen
TOPMed
gnomAD
rs768751032
CA5207001
88 L>F No ClinGen
ExAC
gnomAD
rs747024209
CA5207000
88 L>P No ClinGen
ExAC
gnomAD
rs1468026647
CA374686858
89 R>G No ClinGen
gnomAD
rs1428574713
CA374686855
89 R>I No ClinGen
gnomAD
CA374686856
rs1428574713
89 R>T No ClinGen
gnomAD
CA374686849
rs1159774940
90 A>E No ClinGen
gnomAD
CA5206999
rs775666236
91 D>G No ClinGen
ExAC
TOPMed
gnomAD
CA198899766
rs866972093
92 G>E No ClinGen
Ensembl
rs746375852
CA5206997
92 G>R No ClinGen
ExAC
TOPMed
gnomAD
rs1238253306
CA374686819
95 P>T No ClinGen
gnomAD
CA5206995
rs757672135
96 R>S No ClinGen
ExAC
TOPMed
gnomAD
rs747809936
CA5206994
97 A>S No ClinGen
ExAC
gnomAD
rs550636247
CA5206970
104 Q>E No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
CA5206968
rs200936418
104 Q>H No ClinGen
1000Genomes
ExAC
gnomAD
rs550636247
CA5206969
104 Q>K No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
rs565550412
CA5206966
106 P>R No ClinGen
1000Genomes
ExAC
gnomAD
rs763957233
CA5206964
107 T>I No ClinGen
ExAC
gnomAD
CA5206965
rs753523598
107 T>P No ClinGen
ExAC
TOPMed
gnomAD
CA5206962
rs753019245
108 Q>P No ClinGen
ExAC
gnomAD
rs753019245
CA5206963
108 Q>R No ClinGen
ExAC
gnomAD
CA374686563
rs372685008
109 H>N No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs201333233
CA5206958
109 H>P No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
rs201333233
CA5206959
109 H>R No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
rs372685008
CA5206960
109 H>Y No ClinGen
ESP
ExAC
TOPMed
gnomAD
RCV000947201
CA5206957
VAR_043130
rs16931745
110 F>L No ClinGen
ClinVar
UniProt
1000Genomes
ESP
ExAC
TOPMed
dbSNP
gnomAD
CA374686548
rs1169435031
111 K>R No ClinGen
gnomAD
rs773380295
CA5206956
112 N>K No ClinGen
ExAC
TOPMed
gnomAD
rs770252535
CA5206955
113 Q>L No ClinGen
ExAC
gnomAD
CA5206954
rs746621637
114 F>Y No ClinGen
ExAC
gnomAD
CA5206953
rs779892512
116 A>T No ClinGen
ExAC
CA5206952
rs771882145
117 L>P No ClinGen
ExAC
gnomAD
rs918842271
CA198899603
125 L>Q No ClinGen
gnomAD
CA5206948
rs753883025
126 A>G No ClinGen
ExAC
TOPMed
gnomAD
rs757078623
CA5206949
126 A>T No ClinGen
ExAC
gnomAD
rs1197127247
CA374686444
127 F>S No ClinGen
gnomAD
rs752880973
CA5206945
131 R>* No ClinGen
ExAC
gnomAD
CA5206944
rs370931148
131 R>Q No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs1403226813
CA374686413
132 M>L No ClinGen
TOPMed
gnomAD
rs1403226813
CA374686414
132 M>V No ClinGen
TOPMed
gnomAD
rs192783899
CA374686401
CA374686400
133 N>K No ClinGen
1000Genomes
TOPMed
gnomAD
rs888774101
CA198899600
133 N>S No ClinGen
TOPMed
CA198899598
rs749946059
135 T>A No ClinGen
Ensembl
CA198899596
rs867957370
138 F>L No ClinGen
Ensembl
rs1043903510
CA198899595
141 I>N No ClinGen
TOPMed
CA374686336
rs1477177470
143 E>V No ClinGen
Ensembl
CA5206942
rs368084272
COSM201943
144 S>L Variant assessed as Somatic; 0.0 impact. large_intestine [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
ESP
ExAC
NCI-TCGA
TOPMed
gnomAD
CA374686327
rs1332192451
145 G>R No ClinGen
TOPMed
rs763364067
CA5206940
155 F>L No ClinGen
ExAC
gnomAD
CA374686255
rs1192129602
155 F>Y No ClinGen
gnomAD
CA5206939
rs370283022
156 R>C Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
ESP
ExAC
NCI-TCGA
CA5206938
rs139705441
156 R>H No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs1564344186
CA374686235
158 M>I No ClinGen
Ensembl
CA5206936
rs777159050
158 M>L No ClinGen
ExAC
gnomAD
CA374686232
rs1251829228
159 T>A No ClinGen
gnomAD
CA374686228
rs771795926
159 T>I No ClinGen
ExAC
TOPMed
gnomAD
rs771795926
CA5206935
159 T>N No ClinGen
ExAC
TOPMed
gnomAD
CA374686226
rs1249364761
160 S>P No ClinGen
TOPMed
gnomAD
CA5206933
rs773998277
161 E>Q No ClinGen
ExAC
gnomAD
CA198899593
rs764896114
162 C>Y Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
Ensembl
NCI-TCGA
rs200996697
CA5206931
163 S>R No ClinGen
1000Genomes
ExAC
gnomAD
rs557041991
CA374686161
169 G>D No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
CA5206929
rs756034226
169 G>S No ClinGen
ExAC
TOPMed
gnomAD
CA5206928
rs557041991
169 G>V No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
rs1334265183
CA374686159
COSM1104430
170 R>* Variant assessed as Somatic; 0.0 impact. endometrium [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
NCI-TCGA
gnomAD
rs144487361
CA374686157
170 R>L No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs144487361
CA5206927
170 R>Q No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA5206926
rs755125917
171 P>S Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
gnomAD
CA374686151
rs1408692404
172 N>D No ClinGen
gnomAD
rs867213148
CA198899591
176 S>F No ClinGen
Ensembl
CA374686120
rs1335329920
176 S>P No ClinGen
gnomAD
CA374686105
rs1469676476
178 T>S No ClinGen
TOPMed
gnomAD
CA5206923
rs149700202
182 T>I Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ESP
ExAC
NCI-TCGA
TOPMed
gnomAD
rs149700202
CA5206924
182 T>N No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs928228400
CA198899590
183 K>R No ClinGen
TOPMed
gnomAD
TCGA novel 184 V>A Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1468135390
CA374686063
185 T>R No ClinGen
gnomAD
rs750502102
CA5206922
186 D>E Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
gnomAD
TCGA novel 186 D>N Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1218000940
CA374686051
187 S>N No ClinGen
gnomAD
rs764624230
CA5206919
188 Y>* No ClinGen
ExAC
gnomAD
rs762427267
CA5206920
188 Y>C No ClinGen
ExAC
TOPMed
gnomAD
rs765727909
CA5206921
188 Y>D No ClinGen
ExAC
gnomAD
CA198899589
rs371091768
191 P>S No ClinGen
ESP
TOPMed
gnomAD
rs371091768
CA374686026
191 P>T No ClinGen
ESP
TOPMed
gnomAD
CA374686017
rs1225587127
192 T>I No ClinGen
gnomAD
CA198899588
rs893642296
194 L>F No ClinGen
Ensembl
TCGA novel 194 L>I Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA5206916
rs774192671
196 M>T No ClinGen
ExAC
rs1587897491
CA374685984
197 G>V No ClinGen
Ensembl
rs150498686
CA5206910
203 E>K Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ESP
ExAC
NCI-TCGA
TOPMed
gnomAD
CA5206909
rs754824293
204 V>A No ClinGen
ExAC
gnomAD
rs747201293
CA5206908
205 G>S No ClinGen
ExAC
gnomAD
rs1389685315
CA374685933
205 G>V No ClinGen
gnomAD
TCGA novel 208 W>C Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs895341787
CA198899587
213 Y>* No ClinGen
Ensembl
CA5206906
rs758572471
215 G>R Variant assessed as Somatic; 4.62e-05 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
gnomAD
rs1298405818
CA374685850
217 M>R No ClinGen
gnomAD
CA374685817
rs1463136556
221 Q>H No ClinGen
gnomAD
CA374685809
rs1383002485
222 E>D No ClinGen
gnomAD
CA374685804
rs1182824443
223 G>E No ClinGen
gnomAD
CA5206903
rs138476552
227 M>L No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA374685760
rs754459102
229 N>K No ClinGen
ExAC
TOPMed
gnomAD
CA198899585
rs889534030
230 V>I Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
NCI-TCGA
TOPMed
CA374685742
rs1445362541
232 D>G No ClinGen
gnomAD
rs1283563027
CA374685737
233 I>V No ClinGen
gnomAD
CA198899583
rs7027251
240 K>* No ClinGen
Ensembl
rs1223310365
COSM3847459
CA374685652
245 F>L breast [Cosmic] No ClinGen
cosmic curated
gnomAD
rs764534409
CA5206901
248 A>D No ClinGen
ExAC
gnomAD
TCGA novel 248 A>S Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs901641124
CA198899582
248 A>T No ClinGen
TOPMed
rs1177866256
CA374685611
251 L>V No ClinGen
TOPMed
CA374685607
rs1245749056
252 L>Q No ClinGen
gnomAD

No associated diseases with O95150

1 regional properties for O95150

Type Name Position InterPro Accession
domain Tumour necrosis factor domain 95 - 251 IPR006052

Functions

Description
EC Number
Subcellular Localization
  • Membrane ; Single-pass type II membrane protein
  • ;
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

4 GO annotations of cellular component

Name Definition
extracellular space That part of a multicellular organism outside the cells proper, usually taken to be outside the plasma membranes, and occupied by fluid.
integral component of membrane The component of a membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane.
integral component of plasma membrane The component of the plasma membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane.
plasma membrane The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins.

3 GO annotations of molecular function

Name Definition
cytokine activity The activity of a soluble extracellular gene product that interacts with a receptor to effect a change in the activity of the receptor to control the survival, growth, differentiation and effector function of tissues and cells.
signaling receptor binding Binding to one or more specific sites on a receptor molecule, a macromolecule that undergoes combination with a hormone, neurotransmitter, drug or intracellular messenger to initiate a change in cell function.
tumor necrosis factor receptor binding Binding to a tumor necrosis factor receptor.

5 GO annotations of biological process

Name Definition
activation of cysteine-type endopeptidase activity involved in apoptotic process Any process that initiates the activity of the inactive enzyme cysteine-type endopeptidase in the context of an apoptotic process.
activation of NF-kappaB-inducing kinase activity The stimulation of the activity of NF-kappaB-inducing kinase through phosphorylation at specific residues.
apoptotic process A programmed cell death process which begins when a cell receives an internal (e.g. DNA damage) or external signal (e.g. an extracellular death ligand), and proceeds through a series of biochemical events (signaling pathway phase) which trigger an execution phase. The execution phase is the last step of an apoptotic process, and is typically characterized by rounding-up of the cell, retraction of pseudopodes, reduction of cellular volume (pyknosis), chromatin condensation, nuclear fragmentation (karyorrhexis), plasma membrane blebbing and fragmentation of the cell into apoptotic bodies. When the execution phase is completed, the cell has died.
immune response Any immune system process that functions in the calibrated response of an organism to a potential internal or invasive threat.
signal transduction The cellular process in which a signal is conveyed to trigger a change in the activity or state of a cell. Signal transduction begins with reception of a signal (e.g. a ligand binding to a receptor or receptor activation by a stimulus such as light), or for signal transduction in the absence of ligand, signal-withdrawal or the activity of a constitutively active receptor. Signal transduction ends with regulation of a downstream cellular process, e.g. regulation of transcription or regulation of a metabolic process. Signal transduction covers signaling from receptors located on the surface of the cell and signaling via molecules located within the cell. For signaling between cells, signal transduction is restricted to events at and within the receiving cell.

1 homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
Q8K3Y7 Tnfsf15 Tumor necrosis factor ligand superfamily member 15 Rattus norvegicus (Rat) PR
10 20 30 40 50 60
MAEDLGLSFG ETASVEMLPE HGSCRPKARS SSARWALTCC LVLLPFLAGL TTYLLVSQLR
70 80 90 100 110 120
AQGEACVQFQ ALKGQEFAPS HQQVYAPLRA DGDKPRAHLT VVRQTPTQHF KNQFPALHWE
130 140 150 160 170 180
HELGLAFTKN RMNYTNKFLL IPESGDYFIY SQVTFRGMTS ECSEIRQAGR PNKPDSITVV
190 200 210 220 230 240
ITKVTDSYPE PTQLLMGTKS VCEVGSNWFQ PIYLGAMFSL QEGDKLMVNV SDISLVDYTK
250
EDKTFFGAFL L